Terms: = Testicular cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
16 results:
1. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants.
Gupta S; Farooq A; Rowsey RA; Rahman MA; Shen W; Herrera-Hernandez L; Raghunathan A; Thompson RH; Boorjian SA; Leibovich BC; Cheville JC; Jimenez RE
Hum Pathol; 2022 Jun; 124():85-95. PubMed ID: 35378115
[TBL] [Abstract] [Full Text] [Related]
2. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathologic features of testicular seminoma with syncytiotrophoblastic cells: Analysis of 3 cases and review of the literature].
Liang Y; Tu P; Wang X; Yi XM; Zhou XD; Shi QL
Zhonghua Nan Ke Xue; 2019 Jul; 25(7):642-646. PubMed ID: 32223107
[TBL] [Abstract] [Full Text] [Related]
4. [Pathologic features on gonadal changes of sexual developmental disorders in children].
Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
[No Abstract] [Full Text] [Related]
5. [Clinicopathologic features and expression of oct4 protein in testicular diffuse large B cell lymphoma].
Chen YP; Zhu WF; Chen LF; Lu JP; He TM; Fu WD; Xu CW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):383-387. PubMed ID: 28591984
[No Abstract] [Full Text] [Related]
6. Roles of oct4 in tumorigenesis, cancer therapy resistance and prognosis.
Villodre ES; Kipper FC; Pereira MB; Lenz G
Cancer Treat Rev; 2016 Dec; 51():1-9. PubMed ID: 27788386
[TBL] [Abstract] [Full Text] [Related]
7. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract] [Full Text] [Related]
8. [testicular malignant Leydig cell tumor: A case report].
Lu W; Zhang M; Wang SP; Wang X; Cai ZM
Zhonghua Nan Ke Xue; 2016 May; 22(5):442-5. PubMed ID: 27416670
[TBL] [Abstract] [Full Text] [Related]
9. Recent advances in molecular and cell biology of testicular germ-cell tumors.
Chieffi P
Int Rev Cell Mol Biol; 2014; 312():79-100. PubMed ID: 25262239
[TBL] [Abstract] [Full Text] [Related]
10. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
Chieffi P; Chieffi S
J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
[TBL] [Abstract] [Full Text] [Related]
11. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
Howitt BE; Brooks JD; Jones S; Higgins JP
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathologic analysis of spermatocytic seminoma].
Tian BL; Gao AF; Xu C; Chang XY; Xu ZQ; Su QH; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):752-5. PubMed ID: 23302336
[TBL] [Abstract] [Full Text] [Related]
13. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of oct4.
Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
[TBL] [Abstract] [Full Text] [Related]
14. New prognostic markers and potential therapeutic targets in human testicular germ cell tumors.
Chieffi P
Curr Med Chem; 2011; 18(33):5033-40. PubMed ID: 22050751
[TBL] [Abstract] [Full Text] [Related]
15. oct4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract] [Full Text] [Related]
16. Establishing a germ cell origin for metastatic tumors using oct4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract] [Full Text] [Related]
